-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

705.O1.6 705. Cellular Immunotherapies: Results from CD19-Directed CAR T in treating Aggressive B-cell Lymphomas

Symposia: Cellular Immunotherapies: Late Phase and Commercially Available Therapies Program: Oral and Poster Abstracts
Type: Oral
Hematology Disease Topics & Pathways:
Research, Biological therapies, Lymphoid Leukemias, ALL, clinical trials, adult, Lymphomas, non-Hodgkin lymphoma, Chimeric Antigen Receptor (CAR)-T Cell Therapies, B Cell lymphoma, Clinical Research, Diseases, immune mechanism, Therapies, aggressive lymphoma, real-world evidence, Adverse Events, Lymphoid Malignancies, registries, Biological Processes, Study Population, Human
Sunday, December 11, 2022: 4:30 PM-6:00 PM
Hall E (Ernest N. Morial Convention Center)
Saar Gill, MD, PhD, University of Pennsylvania and Kevin A Hay, MD, MSc, FRCPC, ARRAY(0x10370608)
Hay: Novartis: Honoraria; Jazz Pharmaceuticals: Honoraria; Kite/Gilead: Honoraria; Bristol-Myers-Squibb: Honoraria; Janssen: Research Funding.
4:30 PM

Jeremy S. Abramson, MD1, Scott R. Solomon, MD2, Jon E. Arnason, MD3, Patrick B. Johnston, MD, PhD4, Bertram Glass, MD5*, Veronika Bachanova, MD, PhD6, Sami Ibrahimi, MD7, Stephan Mielke, MD8, Pim Mutsaers, MD9*, Francisco Hernandez-Ilizaliturri, MD10, Koji Izutsu11*, Franck Morschhauser, MD, PhD12*, Matthew A. Lunning, DO, FACP13, Alessandro Crotta, MD14*, Sandrine Montheard, MS14*, Alessandro Previtali, MSc14* and Manali Kamdar, MD, MBBS15*

1Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston
2Northside Hospital Cancer Institute, Atlanta, GA
3Hematologic Malignancy and Bone Marrow Transplantation Program, Beth Israel Deaconess Medical Center, Boston, MA
4Mayo Clinic, Rochester
5Helios Klinikum Berlin-Buch, Berlin, Germany
6Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN
7University of Oklahoma Stephenson Cancer Center, Oklahoma City
8Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Stockholm, Sweden
9Erasmus University Medical Center, Rotterdam, Netherlands
10Roswell Park Comprehensive Cancer Center, Buffalo, NY
11National Cancer Center Hospital, Tokyo, Japan
12Centre Hospitalier Universitaire de Lille. Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France
13University of Nebraska, Omaha, NE
14Celgene, a Bristol-Myers Squibb Company, Boudry, Switzerland
15University of Colorado Cancer Center, Aurora

4:45 PM

Daniel J. Landsburg, MD1, Matthew Frigault, MD, MS2, Michael Heim3*, Stephen Ronan Foley, MD, FRCPC4, Brian T. Hill, MD, PhD5, Christine M. Ho, MD6, Caron A. Jacobson, MD7, Samantha Jaglowski, MD, MPH8, Frederick L. Locke, MD9, Ron Ram, MD10*, Peter A. Riedell, MD11*, Gunjan L. Shah, MD12*, Leslie L. Popplewell, MD, FACP, MPH13, Ranjan Tiwari14*, Stephen Lim, MD15*, Marta Majdan, DPhil15*, Aisha Masood, MD15, Marcelo C Pasquini, MD, MS3 and Cameron J. Turtle, MBBS, PhD16,17

1Department of Medicine, University of Pennsylvania, Philadelphia, PA
2Department of Medicine, Massachusetts General Hospital, Boston, MA
3CIBMTR (Center for International Blood and Marrow Transplant), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
4Juravinski Hospital and Cancer Centre, McMaster University, Hamilton, ON, Canada
5Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH
6Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY
7Department of Medicine, Dana-Farber Cancer Center, Boston, MA
8Department of Internal Medicine, Ohio State University Comprehensive Cancer Center, Columbus, OH
9Department of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL
10BMT Unit, Tel Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
11Department of Medicine, The University of Chicago Medicine, Chicago, IL
12Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
13Department of Hematology and HCT, City of Hope National Medical Center, Duarte, CA
14Novartis Healthcare Pvt. Ltd, Hyderabad, India
15Novartis Pharmaceuticals Corporation, East Hanover, NJ
16Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
17Department of Medicine, University of Washington, Seattle, WA

5:00 PM

Michael Scordo, MD1,2, Jessica R. Flynn, MS3*, Sean M. Devlin, PhD3*, Mithat Gonen, PhD4*, Allison Parascondola, BA5*, Ana Alarcon Tomas, MD6*, Roni Shouval, MD, PhD7, Jamie Brower, MS8*, David L. Porter, MD9, Stephen J. Schuster, MD8, Veronika Bachanova, MD, PhD10, Joseph E. Maakaron, MD11, Richard T. Maziarz, MD12, Loretta J. Nastoupil, MD13, Joseph P. McGuirk, DO14, Olalekan O. Oluwole, MBBS15, Andrew Ip, MD, MSc16, Lori A. Leslie, MD17*, Michael R. Bishop, MD18, Peter A. Riedell, MD18 and Miguel-Angel Perales, MD7

1Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center/New York, New York, NY
2Department of Medicine, Weill Cornell Medical College, New York, NY
3Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
4Department of Epidemiology & Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Hospital Gregorio Marañón, Madrid, ESP
7Adult Bone Marrow Transplant Service, Cellular Therapy Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Division of Hematology-Oncology/Department of Medicine, University of Pennsylvania, Philadelphia, PA
9Cell Therapy and Transplant, Abramson Cancer Center and Hematology-Oncology Division, University of Pennsylvania, Philadelphia, PA
10Division of Hematology, Oncology and Transplantation, Department of Medicine, Masonic Cancer Center, University of Minnesota, Minneapolis, MN
11Division of Hematology, Oncology and Transplantation, University of Minnesota Medical Center, Minneapolis, MN
12Knight Cancer Institute, Oregon Health and Science University, Portland, OR
13Department of Lymphoma and Myeloma, MD Anderson Cancer Center, Houston, TX
14Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, KS
15Vanderbilt University Medical Center, Nashville, TN
16Division of Lymphoma, Division of Outcomes and Value Research, John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
17Division of Lymphoma, John Theuer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
18The David and Etta Jonas Center for Cellular Therapy, University of Chicago, Chicago, IL

5:15 PM

Gloria Iacoboni, MD1*, ANA Africa Martin Lopez2*, Katarzyna Aleksandra Jalowiec3*, Mi Kwon, MD, PhD4*, Kai Rejeski, MD5, Víctor Navarro Garcés6*, Paula Amat, MD PhD7*, Juan Luis Reguera, MD8*, Laura Gallur, MD1*, Sara Gutierrez-Herrero9*, Claire Roddie3*, Gillen Oarbeascoa10*, Ana Benzaquén, MD7*, Cecilia Carpio, MD1*, Lucía López Corral, MD2*, Rafael Hernani, MD7*, Mariana Bastos-Oreiro, MD, PhD10*, Marion Subklewe, MD11, Maeve O'Reilly3*, Lourdes Martín9* and Pere Barba, MD1*

1Vall d’Hebron University Hospital, Barcelona, Spain
2Hematology Department, Hospital Clínico Universitario de Salamanca (CAUSA/IBSAL), Salamanca, Spain
3University College London Hospital NHS Foundation Trust, London, United Kingdom
4Department of Hematology Institute of Health Research Gregorio Marañón, Hospital General Universitario Gregorio Marañón, Madrid, Spain
5Department of Medicine III, University Hospital, LMU Munich, Munich, Germany
6Oncology Data Science (ODysSey) Group, Vall d’Hebron Institute of Oncology (VHIO), BARCELONA, Spain
7Hospital Clínico Universitario de Valencia, Valencia, Spain
8Hospital Universitario Virgen del Rocío, Sevilla, Spain
9Cancer Research Center, Salamanca, Spain
10Gregorio Marañon General University Hospital, Madrid, Spain
11Department of Medicine III (Hematology/Oncology), LMU University Hospital Munich, Muenchen, Germany

5:30 PM

Armin Ghobadi, MD1, Javier Munoz, MD, MS, MBA2, Jason Westin, MD3, Frederick L. Locke, MD4, David B. Miklos, MD, PhD5, Aaron P. Rapoport, MD6, Miguel-Angel Perales, MD7, Patrick M. Reagan, MD8, Joseph P. McGuirk, DO9, Caron A. Jacobson, MD10, Marie José Kersten, MD, PhD11, Irit Avivi, MD12*, Andrew Peng, MS13*, Marco Schupp, MD13*, Christina To, MD13* and Olalekan O. Oluwole, MBBS14

1Washington University School of Medicine, St. Louis, MO
2Banner MD Anderson Cancer Center, Gilbert, AZ
3Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
4Moffitt Cancer Center, Tampa, FL
5Division of BMT and Cellular Therapy, Stanford University, Stanford, CA
6University of Maryland School of Medicine and Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD
7Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8University of Rochester School of Medicine, Rochester, NY
9University of Kansas Cancer Center, Kansas City, KS
10Dana-Farber Cancer Institute, Boston, MA
11Amsterdam UMC, University of Amsterdam, on behalf of HOVON/LLPC, Amsterdam, Netherlands
12Division of Hematology, Tel Aviv University, Tel Aviv, Israel
13Kite, a Gilead Company, Santa Monica, CA
14Vanderbilt University Cancer Center, Nashville, TN

5:45 PM

Ying Wang, MD1, Xudong Wei2*, Dongmei Yan, MD3*, Cheng Zhang, MD, PhD4*, Hongsheng Zhou5*, Chunrong Tong6*, Heng Mei7*, Jie Jin, PhD8, Ting Niu9, Aibin Liang, MD, PhD10*, Jienan Ren11*, Yiping Deng11*, Wei Jin11*, Yi Feng11*, Lin Shi, PhD11*, Yongzeng Wang, PhD11*, Changting Haudenschild, PhD11*, Lulu Lv, PhD12* and Jianxiang Wang, MD1

1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
2Department of Hematology, Affiliated Tumor Hospital of Zhengzhou University, Henan Cancer Hospital,, Zhengzhou, CHN
3Department of hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
4Medical Center of Hematology, Xinqiao Hospital, State Key Laboratory of Trauma, Burn and Combined Injury, Army Medical University, Chongqing, Chongqing, China
5Department of Hematology,, Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, TX, China
6Department of Hematology, Beijing Boren Hospital, Beijing, China
7Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
8Department of Hematology, The First Affiliated Hospital of Zhejiang University, School of Medicine, Hangzhou, China
9West China Hospital of Sichuan University, Chengdu, Sichuan, China
10School of Medicine, Tongji Hospital of Tongji University, Shanghai, China
11Juventas Cell Therapy Ltd, Tianjin, China
12Juventas Cell Therapy Ltd., Tianjin, China

*signifies non-member of ASH